These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11221698)

  • 1. [Lymphatic filariasis].
    Sante; 2000; 10(5):360-1. PubMed ID: 11221698
    [No Abstract]   [Full Text] [Related]  

  • 2. Elimination of transmission of lymphatic filariasis in Egypt.
    Molyneux DH
    Lancet; 2006 Mar; 367(9515):966-8. PubMed ID: 16564345
    [No Abstract]   [Full Text] [Related]  

  • 3. Elimination of lymphatic filariasis.
    Michael E; Malecela-Lazaro MN; Kazura JW
    Lancet; 2006 Jul; 368(9533):362-3; author reply 363-4. PubMed ID: 16876654
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P; Supali T; Maizels RM
    Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of albendazole for lymphatic filariasis.
    Horton J
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S33-40. PubMed ID: 19843396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
    Wkly Epidemiol Rec; 2012 Nov; 87(48):478-82. PubMed ID: 23213667
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphatic filariasis.
    Thompson B
    Nurs Times; 2001 Sep 20-26; 97(38):59-60. PubMed ID: 11935860
    [No Abstract]   [Full Text] [Related]  

  • 8. Major progress toward eliminating lymphatic filariasis.
    Ottesen EA
    N Engl J Med; 2002 Dec; 347(23):1885-6. PubMed ID: 12466515
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 May; 78(20):171-9. PubMed ID: 12808788
    [No Abstract]   [Full Text] [Related]  

  • 10. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
    Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
    Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
    Hooper PJ; Bradley MH; Biswas G; Ottesen EA
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic filariasis elimination programme in India: progress and challenges.
    Ramaiah KD
    Trends Parasitol; 2009 Jan; 25(1):7-8. PubMed ID: 19008150
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of albendazole in programmes to eliminate lymphatic filariasis.
    Ottesen EA; Ismail MM; Horton J
    Parasitol Today; 1999 Sep; 15(9):382-6. PubMed ID: 10461168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the epidemiology, transmission and control of lymphatic filariasis.
    Das PK; Subramanian S
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S153-64. PubMed ID: 12625928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
    McCarthy J
    Am J Trop Med Hyg; 2005 Aug; 73(2):232-3. PubMed ID: 16103580
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphatic filariasis.
    Prescrire Int; 2008 Feb; 17(93):36. PubMed ID: 18383658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
    Gustavsen KM; Bradley MH; Wright AL
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
    Stolk WA; Swaminathan S; van Oortmarssen GJ; Das PK; Habbema JD
    J Infect Dis; 2003 Nov; 188(9):1371-81. PubMed ID: 14593597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migration and dispersal of lymphatic filariasis in Papua New Guinea.
    Alexander ND; Bockarie MJ; Dimber ZB; Griffin L; Kazura JW; Alpers MP
    Trans R Soc Trop Med Hyg; 2001; 95(3):277-9. PubMed ID: 11490996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.